Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NDRG4 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | HRH3 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | TRO | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | CNTN4 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | RNF38 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | SPPL2C | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | PCDHA5 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | TCEAL2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | TMEM63C | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | PODXL2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |